An extremely high dose of losartan affords superior renoprotection in the remnant model
- 1 May 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 67 (5), 1913-1924
- https://doi.org/10.1111/j.1523-1755.2005.00290.x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Safety and Tolerability of High-Dose Angiotensin Receptor Blocker Therapy in Patients with Chronic Kidney Disease: A Pilot StudyAmerican Journal of Nephrology, 2004
- Renal expression of COX-2, ANG II, and AT1receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatoryAmerican Journal of Physiology-Renal Physiology, 2004
- Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive ratsKidney International, 2004
- Renoprotection by ACE Inhibition or Aldosterone Blockade Is Blood Pressure–DependentHypertension, 2003
- Proinflammatory gene expression and macrophage recruitment in the rat remnant kidneyKidney International, 2000
- Activation of mesangial cell signaling cascades in response to mechanical strainKidney International, 1999
- Angiotensin II Is Mitogenic for Cultured Rat Glomerular Endothelial CellsHypertension, 1996
- Activation of human peripheral monocytes by angiotensin IIFEBS Letters, 1994
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- Renal injury from angiotensin II-mediated hypertension.Hypertension, 1992